Free Trial

Progyny Q1 2023 Earnings Report

Progyny logo
$22.62 +0.72 (+3.26%)
As of 10:10 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Progyny EPS Results

Actual EPS
$0.18
Consensus EPS
$0.08
Beat/Miss
Beat by +$0.10
One Year Ago EPS
$0.05

Progyny Revenue Results

Actual Revenue
$258.40 million
Expected Revenue
$246.63 million
Beat/Miss
Beat by +$11.77 million
YoY Revenue Growth
+50.10%

Progyny Announcement Details

Quarter
Q1 2023
Time
After Market Closes

Conference Call Resources

Remove Ads

Progyny Earnings Headlines

The unusual signal flashing green again
Something fascinating happened in April... While a lot of Wall Street institutions were opening new positions in a falling stock, something different showed up on my screen. A special set of candles had just turned green - signaling the kind of momentum surge I'd seen only a handful of times before. What happened next? The stock soared 45% on the underlying stock in just a few weeks and 227% for anyone who traded the options. Naturally, there would have been smaller wins and those that would not have worked out, but this wasn't some penny stock or crypto play… It was ARM Holdings - a major semiconductor player that had just shed 9% of its value.
See More Progyny Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Progyny? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Progyny and other key companies, straight to your email.

About Progyny

Progyny (NASDAQ:PGNY), a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

View Progyny Profile

More Earnings Resources from MarketBeat